Lee Honigberg

6.9k total citations · 3 hit papers
42 papers, 3.5k citations indexed

About

Lee Honigberg is a scholar working on Radiology, Nuclear Medicine and Imaging, Ophthalmology and Molecular Biology. According to data from OpenAlex, Lee Honigberg has authored 42 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Ophthalmology and 12 papers in Molecular Biology. Recurrent topics in Lee Honigberg's work include Retinal Diseases and Treatments (12 papers), Alzheimer's disease research and treatments (10 papers) and Retinal Imaging and Analysis (9 papers). Lee Honigberg is often cited by papers focused on Retinal Diseases and Treatments (12 papers), Alzheimer's disease research and treatments (10 papers) and Retinal Imaging and Analysis (9 papers). Lee Honigberg collaborates with scholars based in United States, Germany and United Kingdom. Lee Honigberg's co-authors include Zhengying Pan, Joseph J. Buggy, Ashley M. Smith, Mint Sirisawad, Erik Verner, Betty Chang, Richard A. Miller, Douglas H. Thamm, David Loury and Cynthia Kenyon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Lee Honigberg

42 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

2010 1.2k citations Lee Honigberg, Ashley M. Smith et al. Proceedings of the National Academy of Sciences profile →
Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase

2006 517 citations Zhengying Pan, Heleen Scheerens et al. ChemMedChem profile →
Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration

2018 264 citations Frank G. Holz, Srinivas R. Sadda et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lee Honigberg United States	19	1.3k	1.2k	802	796	504	42	3.5k
Mariona Graupera Spain	35	2.4k 1.8×	603 0.5×	328 0.4×	493 0.6×	88 0.2×	59	4.6k
Karen Cichowski United States	35	3.6k 2.7×	516 0.4×	478 0.6×	466 0.6×	173 0.3×	58	6.6k
Till Acker Germany	39	3.0k 2.2×	668 0.6×	348 0.4×	407 0.5×	139 0.3×	84	5.4k
Vinay K. Puduvalli United States	38	1.9k 1.5×	2.2k 1.9×	251 0.3×	367 0.5×	354 0.7×	170	4.6k
Edward V. Ball United Kingdom	17	3.8k 2.9×	262 0.2×	323 0.4×	222 0.3×	75 0.1×	23	5.9k
Sandra Pastorino United States	32	3.0k 2.3×	1.7k 1.4×	238 0.3×	718 0.9×	243 0.5×	59	6.3k
Allan J. Yates United States	34	2.2k 1.6×	2.6k 2.2×	171 0.2×	315 0.4×	368 0.7×	100	4.6k
Haoqiang Ying United States	33	5.3k 4.0×	764 0.7×	337 0.4×	807 1.0×	117 0.2×	59	8.4k
Ichiro Nakano United States	43	4.7k 3.6×	1.8k 1.6×	235 0.3×	555 0.7×	163 0.3×	106	7.3k
Jonathan A. Pachter United States	32	2.4k 1.8×	181 0.2×	256 0.3×	741 0.9×	131 0.3×	137	4.4k

Countries citing papers authored by Lee Honigberg

Since Specialization

Citations

This map shows the geographic impact of Lee Honigberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Honigberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Honigberg more than expected).

Fields of papers citing papers by Lee Honigberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Honigberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Honigberg. The network helps show where Lee Honigberg may publish in the future.

Co-authorship network of co-authors of Lee Honigberg

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Honigberg. A scholar is included among the top collaborators of Lee Honigberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Honigberg. Lee Honigberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schofield, CJ, Randall Dere, Juliane Siebourg‐Polster, et al.. (2025). Proteomics approach identifies aqueous humor biomarkers in retinal diseases. Communications Medicine. 5(1). 134–134. 4 indexed citations

Schauer, Stephen, Balázs István Tóth, Julie Lee, et al.. (2024). Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology. Alzheimer s & Dementia. 20(12). 8855–8866. 7 indexed citations

Edmonds, Rose, et al.. (2023). The Role of the Complement Pathway in Clinical Progression of Geographic Atrophy. SHILAP Revista de lepidopterología. 3(4). 100301–100301. 4 indexed citations

Chang, Dolly S., Natalia F. Callaway, Karl G. Csaky, et al.. (2023). Macular Sensitivity Endpoints in Geographic Atrophy. SHILAP Revista de lepidopterología. 4(1). 100351–100351. 22 indexed citations

Schmitz-Valckenberg, Steffen, Marlene Saßmannshausen, Simon S. Gao, et al.. (2023). Interreader Agreement and Longitudinal Progression of Incomplete/Complete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration. Ophthalmology Retina. 7(12). 1059–1068. 4 indexed citations

Anegondi, Neha, Simon S. Gao, Richard F. Spaide, et al.. (2022). Deep Learning to Predict Geographic Atrophy Area and Growth Rate from Multimodal Imaging. Ophthalmology Retina. 7(3). 243–252. 33 indexed citations

Schmitz-Valckenberg, Steffen, Sarah Thiele, Daniela Ferrara, et al.. (2021). Conversion from Intermediate Age-Related Macular Degeneration to Geographic Atrophy in a Proxima B Subcohort Using a Multimodal Approach. Ophthalmologica. 244(6). 523–534. 5 indexed citations

Clayton, David, Alexandre Coimbra, Farshid Faraji, et al.. (2021). Resting-state functional magnetic resonance imaging in a randomized clinical trial for Alzheimer's disease. SHILAP Revista de lepidopterología. 1(4). 100055–100055. 1 indexed citations

Khanani, Arshad M., Vrinda Hershberger, Dante J. Pieramici, et al.. (2021). Phase 1 Study of the Anti-HtrA1 Antibody-binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-related Macular Degeneration. American Journal of Ophthalmology. 232. 49–57. 24 indexed citations

10.

Tom, Irene, Victoria C. Pham, Kenneth J. Katschke, et al.. (2020). Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy. Proceedings of the National Academy of Sciences. 117(18). 9952–9963. 40 indexed citations

11.

Honigberg, Lee, et al.. (2020). Lampalizumab inhibits ocular alternative complement activity in patients with geographic atrophy secondary to age-related macular degeneration. Investigative Ophthalmology & Visual Science. 61(7). 2992–2992. 1 indexed citations

12.

Yoshida, Kenta, Tobias Bittner, Susanne Ostrowitzki, et al.. (2020). Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer’s disease. Alzheimer s Research & Therapy. 12(1). 16–16. 37 indexed citations

13.

Pieramici, Dante J., Arshad M. Khanani, Flávia Brunstein, et al.. (2020). Phase 1 safety study of intravitreal (ITV) Anti-High Temperature Requirement A1 (aHtrA1), a novel serine protease inhibitor, in patients with Geographic Atrophy (GA). Investigative Ophthalmology & Visual Science. 61(7). 1942–1942. 1 indexed citations

14.

Friesenhahn, Michel, Christina Rabe, Simon S. Gao, et al.. (2020). Initial lesion growth rates and other baseline prognostic factors can improve the design of clinical trials in Geographic Atrophy (GA). Investigative Ophthalmology & Visual Science. 61(7). 2988–2988. 2 indexed citations

15.

Pieramici, Dante J., Frank G. Holz, Jeffrey S. Heier, et al.. (2018). Lampalizumab for geographic atrophy (GA) in age-related macular degeneration (AMD): pooled results of the Chroma and Spectri phase 3 randomized clinical trials (RCTs). Investigative Ophthalmology & Visual Science. 59(9). 4948–4948. 2 indexed citations

16.

Yaspan, Brian L., David F. Williams, Frank G. Holz, et al.. (2017). Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration. Science Translational Medicine. 9(395). 148 indexed citations

17.

Wildsmith, Kristin R., Stephen Schauer, Ashley M. Smith, et al.. (2014). Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics. Molecular Neurodegeneration. 9(1). 22–22. 100 indexed citations

18.

MacGlashan, Donald W., Lee Honigberg, Ashley Smith, Joseph J. Buggy, & John T. Schroeder. (2011). Inhibition of IgE-mediated secretion from human basophils with a highly selective Bruton's tyrosine kinase, Btk, inhibitor. International Immunopharmacology. 11(4). 475–479. 50 indexed citations

19.

MacPartlin, Mary, Ashley M. Smith, Brian Druker, Lee Honigberg, & Michael W. Deininger. (2008). Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells. Leukemia. 22(7). 1354–1360. 9 indexed citations

20.

Pan, Zhengying, Heleen Scheerens, Shyr‐Jiann Li, et al.. (2006). Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase. ChemMedChem. 2(1). 58–61. 517 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact